CPC C07K 16/2803 (2013.01) [A61K 38/47 (2013.01); A61K 39/001113 (2018.08); A61K 39/3955 (2013.01); A61K 47/6815 (2017.08); A61K 47/6849 (2017.08); A61P 25/28 (2018.01); C12N 9/2402 (2013.01); C12Y 302/01018 (2013.01); A61K 2039/505 (2013.01); A61M 25/0097 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01)] | 7 Claims |
1. A method of treating a neurodegenerative disease comprising: exposing one or more of a subject's microglia, macrophage and/or other phagocytic cells to an anti-CD22 antibody wherein said exposing treats said neurodegenerative disease wherein said neurodegenerative disease is Niemann-Pick disease Type C (NPC).
|